Company Filing History:
Years Active: 2007
Title: Glen McEnroe: Innovator in Pharmaceutical Chemistry
Introduction
Glen McEnroe is a notable inventor based in San Mateo, CA. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of inhibitors for p38 kinase. His work is essential for advancing treatments for various medical conditions.
Latest Patents
Glen McEnroe holds a patent for "Piperidine/piperazine-type inhibitors of p38 kinase." This patent describes compounds that are useful for treating conditions mediated by p38 kinase. The specific formula and substituents defined in the patent highlight the innovative nature of his work.
Career Highlights
Glen McEnroe is associated with Scios Inc., a company that focuses on developing innovative therapies. His role at Scios Inc. has allowed him to contribute to groundbreaking research and development in the pharmaceutical industry.
Collaborations
Throughout his career, Glen has collaborated with talented individuals such as Babu J Mavunkel and Sundeep Dugar. These collaborations have fostered a creative environment that promotes innovation and scientific advancement.
Conclusion
Glen McEnroe's contributions to pharmaceutical chemistry and his innovative patent work exemplify his commitment to improving medical treatments. His collaborations and career at Scios Inc. further highlight his impact in the field.